March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 11, 2025

FDA's New Pulse Oximeter Guidance: Stricter Standards, Ongoing Challenges

The FDA's 2025 pulse oximetry guidance introduces stricter accuracy standards, larger study cohorts, and objective skin pigmentation assessment to address measurement bias in darker-skinned patients.

Conexiant

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

March 06, 2025

Younger Age, Active SLE, Prednisone Tied to Pericarditis Recurrence

Researchers found that younger age, active systemic lupus erythematosus, and prednisone use significantly increase the risk of recurrent pericarditis in lupus patients.

Conexiant

March 06, 2025

Diabetes Control Declines, Especially Among Young Adults

Researchers find that U.S. diabetes prevalence remained stable from 2013 to 2023, but glycemic control worsened, particularly in young adults, a trend associated with increased cardiovascular risk.

Conexiant

March 06, 2025

Medicaid Cuts: A Direct Hit to Care

An article explores the repercussions of proposed Medicaid cuts by U.S. House Republicans in California, revealing personal struggles and opposition to the potential changes.

KFF Health News

March 06, 2025

Study Examines SGLT2 Inhibitor Use Before Surgery and Diabetic Ketoacidosis Risk

Researchers found no significant association between preoperative sodium-glucose cotransporter 2 inhibitor use and postoperative diabetic ketoacidosis in patients undergoing emergency surgery.

Conexiant

March 05, 2025

FDA Monthly Round-Up: Key February Updates

February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.

Conexiant

March 04, 2025

FDA Approves Prefilled Syringe for Cortrophin Gel

FDA approves a prefilled syringe format for Purified Cortrophin Gel, reducing administration steps for patients with inflammatory and autoimmune conditions.

Conexiant